+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Digital Molybdenum-Rhodium Dual Target Breast Imaging Machine Market by End User, Technology, Application, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082968
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Revolutionizing Breast Imaging with Dual Target Technology

The advent of a digital and dual‐target approach in breast imaging marks a pivotal evolution in early cancer detection and diagnostic precision. By harnessing molybdenum’s capability for enhanced contrast in soft tissue and rhodium’s superior penetration for dense breast tissue, this novel modality merges the strengths of two targets into a unified imaging workflow. Clinicians now gain unprecedented clarity across a broad spectrum of patient anatomies, fostering more accurate lesion identification and reducing the need for follow-up examinations.

This next-generation system also integrates advanced image processing algorithms that refine noise reduction and optimize dynamic range, translating raw detector data into clinically actionable images. Beyond technical sophistication, the dual-target architecture streamlines equipment maintenance: interchangeable targets can be calibrated on demand, minimizing downtime and maximizing throughput. The resulting synergy promises to elevate patient experience, bolster diagnostic confidence, and redefine operational efficiency for providers committed to cutting-edge women’s health care.

Emerging Paradigm Changes Shaping Diagnostic Imaging

Breast imaging is undergoing a profound transformation driven by digital innovation, artificial intelligence, and patient-centric service models. Imaging centers are migrating from standalone digital mammography to integrated platforms capable of synthesizing tomosynthesis data in real time. Algorithms trained on extensive datasets now assist radiologists in differentiating benign findings from malignancies, slashing reading times and error rates.

Simultaneously, the expansion of mobile screening units has brought state-of-the-art imaging directly into underserved communities, fostering earlier detection in regions previously limited by infrastructure constraints. Teaching hospitals and research institutes are collaborating with technology vendors to validate novel contrast agents and imaging biomarkers, accelerating the pipeline from bench to bedside. These converging shifts-automation, decentralization, and translational research-are collectively reshaping diagnostic pathways and challenging legacy models of care.

Navigating Tariff Implications on Imaging Equipment

With the implementation of new United States tariffs in 2025, diagnostic imaging equipment manufacturers and providers face an altered cost structure. Import duties on components critical to molybdenum-rhodium target assemblies and high-precision detectors have increased procurement expenses and compression of vendor margins. As a result, suppliers are renegotiating contracts, assessing domestic manufacturing partnerships, and considering price adjustments for end users.

Healthcare facilities are evaluating capital budgets more rigorously, prioritizing equipment with predictable maintenance costs and long-term service agreements. To mitigate the impact of tariffs, some organizations are adopting modular system architectures that allow critical components to be sourced locally, thus reducing exposure to import duties. Others are bundling imaging systems with value-added software licenses to justify adjusted price points. Despite these headwinds, the demand for next-generation breast imaging remains robust, fueled by growing screening guidelines and the imperative for early detection.

Unveiling Market Drivers through Segmentation Analysis

A granular view of the market reveals distinct opportunities within academic and research settings, where partnerships between research institutes and teaching hospitals drive validation studies and clinical trials. Fixed breast cancer screening clinics and mobile units are extending reach into both urban centers and rural communities, while chain-based diagnostic imaging centers leverage scale to negotiate favorable service contracts. Independent centers differentiate through personalized patient care, and hospitals-both private and public-integrate advanced imaging suites into broader women’s health programs.

On the technology front, two-dimensional digital mammography remains a cornerstone for routine exams, yet digital breast tomosynthesis is rapidly gaining ground. Within tomosynthesis, platforms featuring artificial intelligence-enabled reconstruction algorithms and contrast-enhanced imaging capabilities are capturing the interest of early adopters, even as conventional tomosynthesis maintains a strong presence in established screening workflows.

Applications of this dual‐target modality encompass biopsy guidance, where precise localization reduces sampling error, and diagnostic uses such as lesion characterization and pre-surgical planning. Screening protocols are bifurcating to address both routine population exams and high-risk patient monitoring, ensuring tailored imaging regimens. Distribution channels reflect a dual approach: direct sales relationships with large health systems complemented by distributor networks that serve regional and specialized care providers, accelerating market penetration across diverse clinical settings.

Regional Dynamics Driving Adoption Trends

Across the Americas, robust reimbursement frameworks and a high prevalence of organized screening initiatives sustain rapid adoption of advanced imaging modalities. North American providers invest heavily in tomosynthesis upgrades, and Latin American markets are witnessing growing demand as government programs expand women’s health outreach.

In Europe, Middle East and Africa, harmonized medical device regulations such as the EU’s MDR encourage the rollout of certified digital imaging solutions, while private-public partnerships in the Middle East fund large-scale diagnostic centers. African markets, though nascent, are drawing international collaborations aimed at building screening capacity and training local radiologists to reduce reliance on imported expertise.

In Asia-Pacific, emerging economies are balancing infrastructure expansion with cost containment, leading to selective rollouts of dual-target systems in premier teaching hospitals and private diagnostics chains. Government-sponsored screening drives in countries like China and South Korea stimulate demand for high-throughput units, while Australia and Japan continue to refine screening guidelines, placing a premium on image quality and patient comfort.

High-Impact Players Steering Market Evolution

Global imaging vendors and specialized start-ups are jockeying for position in the dual-target breast imaging arena. Established players leverage extensive service networks to bundle innovative hardware with predictive analytics software, strengthening customer loyalty and creating barriers for new entrants. Strategic alliances between technology companies and academic centers accelerate product validation and clinical acceptance, speeding time-to-market for enhancements such as AI-driven lesion detection and contrast-enhanced protocols.

Meanwhile, nimble specialized manufacturers focus on modular designs that allow rapid customization for niche use cases, appealing to facilities with unique workflow requirements. Collaborative investment in the development of standardized data formats and interoperability frameworks ensures that new dual-target systems can seamlessly integrate into electronic health record platforms, further improving adoption rates and user satisfaction.

Strategic Imperatives for Competitive Advantage

Industry leaders must cultivate strategic partnerships that span the supply chain, from materials sourcing to software integration, to ensure resilience against geopolitical and tariff-related disruptions. Investing in R&D collaborations with academic and research institutes will validate novel applications-such as contrast-enhanced tomosynthesis-that can differentiate offerings in a competitive marketplace.

Providers should explore co-development agreements with AI vendors to embed advanced detection algorithms, thereby enhancing diagnostic accuracy and radiologist productivity. Expanding mobile screening services can capture underserved patient segments and demonstrate social responsibility, while tiered pricing models tailored to routine versus high-risk screening can optimize utilization across diverse clinical settings. Strengthening relationships with reimbursement bodies and demonstrating clear value propositions through health economics studies will be critical to securing favorable payment pathways.

Finally, industry participants should adopt a modular platform approach, enabling incremental upgrades to tomosynthesis capabilities without requiring full system replacement. This flexibility will attract budget-conscious buyers and extend equipment lifecycles, delivering both clinical excellence and sustainable financial returns.

Rigorous Methods Underpinning Market Assessment

Our analysis is grounded in a multi-tiered methodology that combines primary interviews with radiology department heads, medical physicists, procurement specialists, and technology vendors with exhaustive secondary research. Publicly available regulatory filings, peer-reviewed literature, and conference proceedings were synthesized to validate performance metrics and adoption drivers.

Quantitative data on installed base, shipment volumes, and regional uptake were triangulated with qualitative insights on purchasing criteria, service preferences, and emerging clinical workflows. Segment definitions and regional breakdowns were refined through iterative consultations with subject-matter experts, ensuring that our segmentation framework reflects real-world decision processes. All findings underwent internal peer review to uphold the highest standards of accuracy and relevance.

Synthesis of Insights and Forward Outlook

The convergence of digital dual-target technology, advanced image analytics, and evolving service delivery models is charting a new course for breast imaging. By illuminating distinct market segments, revealing regional dynamics, and decoding the strategic moves of key players, this executive summary provides a foundational roadmap for informed decision-making.

As organizations navigate tariff complexities, shifting reimbursement landscapes, and the imperative for early detection, the insights presented here will help align technology investment with clinical and financial objectives. With a clear understanding of segmentation nuances and regional variances, decision-makers are better equipped to harness the transformative potential of molybdenum-rhodium dual target systems, ultimately improving patient outcomes and strengthening competitive positioning.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • End User
    • Academic And Research Institutes
      • Research Institutes
      • Teaching Hospitals
    • Breast Cancer Screening Centers
      • Fixed Screening Clinics
      • Mobile Screening Units
    • Diagnostic Imaging Centers
      • Chain Based Centers
      • Independent Centers
    • Hospitals
      • Private Hospitals
      • Public Hospitals
  • Technology
    • 2D Digital Mammography
    • Digital Breast Tomosynthesis
      • AI Enabled Tomosynthesis
      • Contrast Enhanced Tomosynthesis
      • Conventional Tomosynthesis
  • Application
    • Biopsy Guidance
    • Diagnostic
      • Lesion Characterization
      • Pre Surgical Planning
    • Screening
      • High Risk Screening
      • Routine Screening
  • Distribution Channel
    • Direct Sales
    • Distributors
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Hologic, Inc.
  • GE Healthcare
  • Siemens Healthineers AG
  • FUJIFILM Holdings Corporation
  • Konica Minolta, Inc.
  • Carestream Health, Inc.
  • Shimadzu Corporation
  • Planmed Oy
  • IMS Giotto S.p.A.
  • Dilon Technologies, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Digital Molybdenum-Rhodium Dual Target Breast Imaging Machine Market, by End User
8.1. Introduction
8.2. Academic And Research Institutes
8.2.1. Research Institutes
8.2.2. Teaching Hospitals
8.3. Breast Cancer Screening Centers
8.3.1. Fixed Screening Clinics
8.3.2. Mobile Screening Units
8.4. Diagnostic Imaging Centers
8.4.1. Chain Based Centers
8.4.2. Independent Centers
8.5. Hospitals
8.5.1. Private Hospitals
8.5.2. Public Hospitals
9. Digital Molybdenum-Rhodium Dual Target Breast Imaging Machine Market, by Technology
9.1. Introduction
9.2. 2D Digital Mammography
9.3. Digital Breast Tomosynthesis
9.3.1. AI Enabled Tomosynthesis
9.3.2. Contrast Enhanced Tomosynthesis
9.3.3. Conventional Tomosynthesis
10. Digital Molybdenum-Rhodium Dual Target Breast Imaging Machine Market, by Application
10.1. Introduction
10.2. Biopsy Guidance
10.3. Diagnostic
10.3.1. Lesion Characterization
10.3.2. Pre Surgical Planning
10.4. Screening
10.4.1. High Risk Screening
10.4.2. Routine Screening
11. Digital Molybdenum-Rhodium Dual Target Breast Imaging Machine Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
12. Americas Digital Molybdenum-Rhodium Dual Target Breast Imaging Machine Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Digital Molybdenum-Rhodium Dual Target Breast Imaging Machine Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Digital Molybdenum-Rhodium Dual Target Breast Imaging Machine Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Hologic, Inc.
15.3.2. GE Healthcare
15.3.3. Siemens Healthineers AG
15.3.4. FUJIFILM Holdings Corporation
15.3.5. Konica Minolta, Inc.
15.3.6. Carestream Health, Inc.
15.3.7. Shimadzu Corporation
15.3.8. Planmed Oy
15.3.9. IMS Giotto S.p.A.
15.3.10. Dilon Technologies, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET MULTI-CURRENCY
FIGURE 2. DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET MULTI-LANGUAGE
FIGURE 3. DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY FIXED SCREENING CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY MOBILE SCREENING UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY CHAIN BASED CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY 2D DIGITAL MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY AI ENABLED TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY CONTRAST ENHANCED TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY CONVENTIONAL TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BIOPSY GUIDANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY LESION CHARACTERIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY PRE SURGICAL PLANNING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HIGH RISK SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ROUTINE SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 69. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 70. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 71. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 72. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 74. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 76. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 77. CANADA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 80. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 83. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 87. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 88. MEXICO DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 130. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 132. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 136. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 137. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 138. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 139. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 141. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 143. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 144. GERMANY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 147. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 148. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 150. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 152. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 154. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 155. FRANCE DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 165. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 166. RUSSIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 169. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 170. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 171. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 174. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 176. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 177. ITALY DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 180. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 181. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 182. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 183. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 185. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 187. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 188. SPAIN DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 199. UNITED ARAB EMIRATES DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 204. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC, 2018-2030 (USD MILLION)
TABLE 220. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY SCREENING, 2018-2030 (USD MILLION)
TABLE 221. SOUTH AFRICA DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. DENMARK DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. DENMARK DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 224. DENMARK DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY BREAST CANCER SCREENING CENTERS, 2018-2030 (USD MILLION)
TABLE 225. DENMARK DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 226. DENMARK DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 227. DENMARK DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. DENMARK DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SIZE, BY DIGITAL BREAST TOMOSYNTHESIS, 2018-2030 (USD MILLION)
TABLE 229. DENMARK DIGITAL MOLYBDENUM-RHODIUM DUAL TARGET BREAST IMAGING MACHINE MARKET SI

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Digital Molybdenum-Rhodium Dual Target Breast Imaging Machine market report include:
  • Hologic, Inc.
  • GE Healthcare
  • Siemens Healthineers AG
  • FUJIFILM Holdings Corporation
  • Konica Minolta, Inc.
  • Carestream Health, Inc.
  • Shimadzu Corporation
  • Planmed Oy
  • IMS Giotto S.p.A.
  • Dilon Technologies, Inc.